Table 1. Applications to the WHO Expert Committee on the Selection and Use of Essential Medicines, 2002–2013.
| Application characteristic | No. of applications (%) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Meeting of the WHO Expert committee (year) |
Total | |||||||
| 12th (2002) | 13th (2003) | 14th (2005) | 15th (2007) | 17th (2009) | 18th (2011) | 19th (2013) | ||
| Applications | 16 (100) | 7 (100) | 17 (100) | 22 (100) | 35 (100) | 17 (100) | 20 (100) | 134 (100) |
| Additions to the list | 11 (68.8) | 3 (42.9) | 7 (41.2) | 19 (86.4) | 12 (34.3) | 10 (58.8) | 10 (50.0) | 72 (53.7) |
| Applicant | ||||||||
| WHO (internal) | 12 (75.0) | 4 (57.1) | 2 (11.8) | 7 (31.8) | 4 (11.4) | 3 (17.6) | 2 (10.0) | 34 (25.4) |
| Academia | 0 (0.0) | 1 (14.3) | 1 (5.9) | 3 (13.6) | 15 (42.9) | 6 (35.3) | 4 (20.0) | 30 (22.4) |
| NGO | 0 (0.0) | 2 (28.6) | 5 (29.4) | 3 (13.6) | 11 (31.4) | 0 (0.0) | 8 (40.0) | 29 (21.6) |
| Industry | 3 (18.8) | 0 (0.0) | 5 (29.4) | 6 (27.3) | 0 (0.0) | 6 (35.3) | 1 (5.0) | 21 (15.7) |
| Othera | 1 (6.2) | 0 (0.0) | 4 (23.5) | 3 (13.6) | 5 (14.3) | 2 (11.8) | 5 (25.0) | 20 (14.9) |
| Class of medicine | ||||||||
| HIV | 10 (62.5) | 0 (0.0) | 3 (17.6) | 7 (31.8) | 2 (5.7) | 3 (17.6) | 0 (0.0) | 25 (18.7) |
| Infections | 1 (6.3) | 4 (57.1) | 3 (17.6) | 4 (18.2) | 5 (14.3) | 2 (11.8) | 2 (10.0) | 21 (15.7) |
| Mental health | 0 (0.0) | 0 (0.0) | 1 (5.9) | 1 (4.5) | 14 (40.0) | 0 (0.0) | 2 (10.0) | 18 (13.4) |
| Tuberculosis and malaria | 4 (25.0) | 1 (14.3) | 0 (0.0) | 2 (9.1) | 1 (2.9) | 3 (17.6) | 2 (10.0) | 13 (9.7) |
| Cancer | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (4.5) | 4 (11.4) | 3 (17.6) | 4 (20.0) | 12 (9.0) |
| RH and MCH | 0 (0.0) | 1 (14.3) | 7 (41.2) | 2 (9.1) | 2 (5.7) | 0 (0.0) | 0 (0.0) | 12 (9.0) |
| CVD and diabetes | 0 (0.0) | 1 (14.3) | 0 (0.0) | 1 (4.5) | 1 (2.9) | 2 (11.8) | 1 (5.0) | 6 (4.5) |
| Otherb | 1 (6.3) | 0 (0.0) | 3 (17.6) | 4 (18.2) | 6 (17.1) | 4 (23.5) | 9 (45.0) | 27 (20.2) |
CVD: cardiovascular disease; HIV: human immunodeficiency virus; MCH: maternal and child health; NGO: nongovernmental organization; RH: reproductive health; WHO: World Health Organization.
a Government groups and co-applicants of different types (e.g. NGO-academic partnerships).
b Includes analgesics, antidotes, gastrointestinal medicines, antivirals, anaesthesia and sedatives, ophthalmology preparations and nutritional supplements including vitamins and minerals.